FDA Approved: TRI-LO-MILI — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for TRI-LO-MILI (norgestimate and ethinyl estradiol) by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TRI-LO-MILI (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for TRI-LO-MILI (NORGESTIMATE AND ETHINYL ESTRADIOL)